The efficacy of mifepristone in the reduction and prevention of olanzapine-induced weight gain in rats.
Mifepristone reduces weight gain and improves metabolic abnormalities associated with risperidone treatment in normal men.
Glucocorticoid receptor activation inhibits chemotherapy-induced cell death in high-grade serous ovarian carcinoma.
Glucocorticoid receptor activity contributes to resistance to androgen-targeted therapy in prostate cancer.
